Charcot-Marie-Tooth neuropathy type 2O (CMT2O) is a rare, inherited nerve disease. It mainly damages the long nerves in the legs and arms (axonal neuropathy). It is usually caused by changes (mutations) in a gene called DYNC1H1 and is passed on in an autosomal-dominant way, which means one changed copy of the gene is enough to cause the condition. GARD Information Center+2MalaCards+2
Charcot-Marie-Tooth neuropathy type 2O (CMT2O) is a very rare inherited nerve disease that mainly damages the long nerves to the legs and feet. It is an “axonal” form of Charcot-Marie-Tooth, which means the main problem is in the core of the nerve fiber (the axon), not in the myelin covering. In CMT2O there is usually a change (mutation) in one copy of a gene called DYNC1H1, which gives instructions for part of a motor protein called cytoplasmic dynein. This protein is important for moving materials up and down the nerve cell. When it does not work properly, the longest nerves slowly become weak and thin, leading to muscle weakness, loss of feeling, and problems with walking that usually start in childhood or early adult life. Genetic Rare Diseases Center+2MDPI+2
Other names
Charcot-Marie-Tooth neuropathy type 2O has many other names that all describe the same basic condition. Doctors and genetic databases may call it Charcot-Marie-Tooth disease axonal type 2O, autosomal dominant axonal Charcot-Marie-Tooth disease type 2O, Charcot-Marie-Tooth disease, axonal, autosomal dominant, type 2O, Charcot-Marie-Tooth neuropathy, axonal, type 2O, or simply CMT2O. All of these names mean that this is a form of Charcot-Marie-Tooth disease where the damage mainly affects the axon of the peripheral nerve, the inheritance is autosomal dominant, and the main gene involved is DYNC1H1 on chromosome 14. NCBI+2ZFIN+2
Types
Although CMT2O is defined as one named subtype, people with this diagnosis can look quite different from each other. Experts sometimes talk about clinical “types” or patterns inside CMT2O based on which nerves and other systems are involved. One common pattern is a “classic peripheral” form, where the main problem is slowly progressive weakness and wasting of the muscles in the feet and lower legs, with mild loss of feeling and high-arched feet, while nerve conduction tests stay normal or near normal. Orpha.net+1
A second pattern is a form with more widespread limb involvement, where weakness and wasting spread from the feet to the hands and sometimes to muscles closer to the trunk. These patients can have more trouble with hand function, such as buttoning clothes or writing, but still show an axonal neuropathy linked to a DYNC1H1 mutation. NCBI+1
A third pattern is a skeletal-deformity-dominant type, where the most obvious early signs are structural changes like pes cavus (very high foot arches), hammertoes, abnormal posture, joint contractures, or scoliosis. The underlying cause is still the nerve damage, but the bone and joint changes become a major part of the clinical picture over time. Orpha.net+1
A fourth pattern is a “neuromuscular-plus” type, where the peripheral neuropathy is combined with problems in the central nervous system, such as delayed motor milestones, learning difficulties, or spasticity. These cases lie on the broader spectrum of DYNC1H1-related disorders, where the same gene can cause both axonal neuropathy and brain development problems, depending on the exact mutation and other modifying factors. Genetic Rare Diseases Center+2NCBI+2
Finally, there is a mild or very slowly progressive type, sometimes recognized only in mid- or late adulthood, where people may notice only slight weakness, mild balance problems, or subtle foot changes. In these families, CMT2O may be discovered only when detailed nerve studies and genetic testing are done for recurrent ankle sprains or unexplained clumsiness. MDPI+1
Causes
Pathogenic DYNC1H1 gene mutation
The main cause of CMT2O is a harmful change in one copy of the DYNC1H1 gene, which encodes the heavy chain of cytoplasmic dynein 1, a motor protein used for transport inside nerve cells. This mutation disrupts the protein’s normal function and leads to damage of long peripheral nerves, especially those going to the feet and lower legs. NCBI+1Autosomal dominant inheritance
CMT2O usually follows an autosomal dominant pattern, which means that a person only needs one copy of the mutated gene, inherited from either parent, to develop the condition. Each child of an affected person has a 50% chance of inheriting the mutation and the disease. NCBI+1De novo (new) mutations
Some people with CMT2O are the first in their family to have the disease because the DYNC1H1 mutation occurred for the first time in their egg or sperm cell or early embryo. In these “de novo” cases, there is no previous family history, but the affected person can still pass on the mutation to their children. Frontiers+2NCBI+2Mutations in the dynein motor domain
Many DYNC1H1 changes affect the part of the protein that binds to microtubules and uses ATP to generate movement. These motor-domain mutations can severely disturb retrograde axonal transport, making it hard for nerve cells to move cargo back toward the cell body, which contributes to axon degeneration. NCBI+2UniProt+2Mutations in the dynein tail or linker regions
Other mutations affect the N-terminal tail or linker regions that help dynein bind to cargo and partner proteins. Disturbing these regions can prevent proper loading of vesicles, mitochondria, and signaling molecules onto the transport machinery, again stressing the long peripheral axons and promoting neuropathy. UniProt+2ScienceDirect+2Length-dependent axonal vulnerability
The longest nerves, especially those running from the spinal cord to the feet, depend most strongly on retrograde transport to stay healthy. When dynein-based transport is impaired by a DYNC1H1 mutation, these long axons are the first to fail, which explains why weakness and wasting start in the distal lower limbs in CMT2O. NCBI+1Impaired transport of mitochondria
Cytoplasmic dynein helps position mitochondria, the cell’s energy factories, along axons. Faulty DYNC1H1 function can disturb mitochondrial movement and energy distribution, leaving distal nerve segments with too little energy and making them vulnerable to degeneration over time. UniProt+2Ma’ayan Lab+2Impaired transport of trophic and growth factors
Peripheral nerves depend on signals and growth factors carried back from the muscles and skin to the neuron cell body. When dynein-mediated transport is reduced, these signals are not delivered properly, leading to gradual dying back of the axon and clinical neuropathy. Wikipedia+2Wikipedia+2Chronic axonal degeneration
Over many years, the combined transport problems cause ongoing axonal injury and loss of myelinated fibers in nerve biopsies. This chronic degeneration is a key pathological “cause” of the reduced nerve conduction and clinical weakness seen in CMT2O and other axonal CMT forms. NCBI+1Early developmental disruption of motor pathways
DYNC1H1 is important for neuron development and positioning, so mutations can disturb how motor neurons and their axons form in early life. This can cause delayed motor milestones and early-onset weakness, which are common features in CMT2O patients. Genetic Rare Diseases Center+2Frontiers+2Modifier genes and genetic background
People with the same DYNC1H1 mutation can show different severity, suggesting that other genes modify the disease. Variants in genes related to axonal transport, myelin, or ion channels may act as “modifiers,” making the neuropathy milder or more severe in different individuals and families. MDPI+1Combined mutations in multiple genes (rare)
A reported case of CMT2O carried changes in both DYNC1H1 and SLC12A6, a gene linked to another hereditary neuropathy. This suggests that, in rare situations, combined genetic variants may interact and influence the clinical picture, although DYNC1H1 remains the main causal gene for CMT2O. eCommons+1Cellular stress and protein misfolding
Some DYNC1H1 mutations may cause the protein to misfold or assemble poorly into the dynein complex. Misfolding can create cellular stress, activate damage pathways, and further injure long peripheral axons, acting as a molecular cause of the neuropathy. Wikipedia+2ScienceDirect+2Secondary Schwann cell changes
Although CMT2O is an axonal disease, damage to axons can secondarily affect Schwann cells, the cells that make myelin in peripheral nerves. This secondary effect can worsen nerve conduction and contribute to further weakness and sensory loss. NCBI+2www.elsevier.com+2Age-related accumulation of damage
Even though onset is usually in childhood, symptoms often slowly worsen with age as small daily injuries to already fragile axons add up. This gradual wear-and-tear over decades is one reason CMT2O is described as “slowly progressive.” Genetic Rare Diseases Center+1Mechanical stress from abnormal gait and foot shape
High arches, hammertoes, and foot drop change how weight is distributed when walking. This can put extra stress on weakened nerves and muscles, possibly speeding up deformities and making neuropathy symptoms more noticeable over time. Mayo Clinic+1Co-existing DYNC1H1-related central nervous system problems
In some families, the same DYNC1H1 mutation or closely related ones can cause both CMT2O and central nervous system problems such as intellectual disability or seizures. The extra neurological burden can indirectly worsen function in people already dealing with peripheral neuropathy. NCBI+2Wikipedia+2Metabolic or toxic stress on already vulnerable nerves
Conditions like diabetes, vitamin deficiencies, or exposure to certain nerve-toxic drugs do not cause CMT2O by themselves, but if they occur in someone with a DYNC1H1 mutation, they can add extra stress to the nerves and worsen weakness and sensory loss. NCBI+1Lack of early supportive care
When inherited neuropathy is not recognized early, problems such as contractures, scoliosis, or repeated ankle injuries can build up. The absence of early physiotherapy, orthotics, and fall-prevention does not cause CMT2O, but it can make the later disability more severe. NCBI+2Cleveland Clinic+2Random biological variation
Even with the same mutation and similar life conditions, some people develop more severe neuropathy than others. This variation is common in many genetic diseases and reflects small random differences in development and cellular processes that we cannot fully predict, but the underlying cause remains the DYNC1H1 mutation. MDPI+1
Symptoms
Distal lower-limb muscle weakness
The most typical symptom of CMT2O is weakness in the muscles of the feet and lower legs, called distal lower-limb weakness. People may struggle to push off the ground, climb stairs, or stand on their toes, because the nerves to these muscles cannot carry signals properly. MDPI+1Distal muscle wasting (atrophy)
Over time, the weak muscles in the feet and calves can shrink and look thinner than normal, a process called atrophy. This wasting reflects long-standing loss of nerve supply and helps doctors see that the problem is chronic and nerve-related. NCBI+1Difficulty running and poor endurance
Many children with CMT2O are slower than their peers in running and sports, and they may tire quickly when walking or playing. This early difficulty with fast or long-distance movement is often one of the first clues to an underlying inherited neuropathy. Genetic Rare Diseases Center+1Frequent tripping or falls
Weak ankle and foot muscles, along with foot drop, make it easy to trip over small obstacles or uneven ground. Parents and patients may report many sprained ankles or unexplained falls, especially when walking in the dark or on rough surfaces. Mayo Clinic+1Foot drop and steppage gait
Foot drop means the front of the foot cannot be lifted well, so the toes tend to drag on the ground. To avoid this, people may adopt a “steppage gait,” lifting the knees higher with each step, which looks like marching and is typical in many forms of CMT type 2. NCBI+1High-arched feet (pes cavus) and other foot deformities
Over time, weakness and imbalance in foot muscles often lead to high arches, curled toes, or other deformities. These structural changes can make shoe-fitting difficult and further worsen balance and walking ability. Mayo ClinicDistal sensory loss
Some people with CMT2O lose sensation in the toes and feet, including reduced feeling of vibration, light touch, or pain. This sensory loss is usually mild to moderate and variable between patients but can make it hard to detect injuries or pressure points. Genetic Rare Diseases Center+1Neuropathic pain or abnormal sensations
A subset of patients report burning, tingling, or electric-like pain in the feet or legs, which reflects irritated or damaged sensory fibers. Although not universal, neuropathic pain can significantly affect comfort, sleep, and quality of life in CMT2O and other CMT2 forms. MD SearchlightReduced or absent reflexes (hyporeflexia/areflexia)
Because the reflex loop depends on healthy peripheral nerves, many patients have weak or absent ankle and sometimes knee reflexes on exam. This finding supports a peripheral neuropathy and helps distinguish CMT2O from other conditions that might look similar. NCBIWeakness in hands and forearms
As the disease progresses, nerves to the hands may be affected, leading to weakness of grip and fine finger movements. Patients may notice difficulty opening jars, writing for long periods, or doing detailed tasks like buttoning clothing. NCBI+1Delayed motor milestones in childhood
Some children with CMT2O sit, stand, or walk later than expected, or appear clumsy as toddlers. This delay comes from early involvement of lower-limb nerves and muscles and is a common feature in DYNC1H1-related motor disorders. Genetic Rare Diseases Center+2Frontiers+2Abnormal gait and balance problems
Even beyond foot drop, the whole walking pattern may look abnormal: steps may be wide-based, uneven, or high-stepping. Balance, especially when turning quickly or standing on one leg, is often reduced, increasing the risk of falls. Mayo Clinic+1Spinal or joint deformities (scoliosis, contractures) in some patients
In a minority of cases, long-term muscle imbalance leads to scoliosis (sideways bending of the spine) or fixed bending of joints (contractures). These skeletal complications are more often reported in severe or early-onset neuromuscular forms within the DYNC1H1 spectrum, including some CMT2O cases. Genetic Rare Diseases Center+1Fatigue and limited walking distance
Because muscles are weak and nerves are inefficient, walking or standing for long periods can cause marked fatigue. Patients may need to stop more often to rest, avoid long distances, or use supports such as rails, braces, or in some cases walking aids. NCBI+2Cleveland Clinic+2Learning or cognitive difficulties in a subset
A few reported CMT2O patients, especially in the broader DYNC1H1-related disorder group, have learning difficulties or other cognitive issues. This reflects mild central nervous system involvement from the same gene mutation, not a separate brain condition. Genetic Rare Diseases Center+1
Diagnostic tests
Physical examination tests
Detailed neurological and family history
The diagnostic process starts with careful questions about when symptoms began, how they progressed, and whether other family members have similar problems. A pattern of childhood-onset distal weakness and similar symptoms in close relatives strongly suggests an inherited neuropathy such as CMT2O. NCBI+1Inspection of feet, legs, and hands
The doctor examines the shape of the feet for high arches, hammertoes, and calluses, and looks at the calves and hands for muscle wasting. These visible changes, together with thin ankles and “inverted champagne bottle” legs, are classic signs seen in many people with Charcot-Marie-Tooth disease. Mayo Clinic+1Gait and balance assessment
Watching the person walk, turn, run, or stand on one leg helps reveal foot drop, steppage gait, or instability. Difficulty with heel-walking, toe-walking, or tandem (heel-to-toe) walking is common in CMT2 and supports a diagnosis of distal motor neuropathy. NCBI+1Reflex testing
The clinician taps the knee and ankle tendons with a reflex hammer to test deep tendon reflexes. In CMT2O and other CMT2 forms, these reflexes are often reduced or absent at the ankles, which indicates a peripheral neuropathy rather than a central spinal cord problem. NCBI
Manual tests
Manual muscle testing of ankle and foot muscles
The examiner applies resistance while the patient tries to move the feet up, down, in, and out. Weakness of ankle dorsiflexion and toe extension is typical in CMT2O and helps track severity and progression over time. NCBIManual muscle testing of hand and finger muscles
In more advanced cases, hand muscles are tested by asking the patient to spread fingers, pinch, and grip while resistance is applied. Detecting distal hand weakness supports the idea of a length-dependent axonal neuropathy affecting upper limbs as well. NCBI+1Sensory testing with simple tools
Cotton, a pin, tuning fork, and sometimes temperature objects are used to check feeling in the toes, feet, and legs. Reduced vibration or pinprick sensation in a stocking pattern is common in CMT2 and supports involvement of sensory axons. NCBI+1Functional walking tests (e.g., timed walk)
Simple timed tests such as a 10-meter walk or 6-minute walk measure how quickly and how far a patient can walk. These tests do not diagnose CMT2O by themselves, but they give a practical measure of disability and can be repeated to see progression or response to therapy. NCBI+2Cleveland Clinic+2
Lab and pathological tests
Routine blood tests to rule out other neuropathies
Blood tests such as blood sugar, vitamin B12, thyroid levels, and sometimes autoimmune markers are checked to exclude common acquired causes of neuropathy. Normal results support an inherited cause like CMT2O, but they are mainly used to rule out other conditions that can mimic it. NCBI+1Comprehensive CMT genetic panel
A genetic test panel that includes many neuropathy genes is often used when CMT is suspected. These panels commonly include DYNC1H1 among many CMT-associated genes, and identifying a pathogenic variant confirms the molecular diagnosis of CMT2O. NCBITargeted DYNC1H1 gene sequencing
If clinical and nerve study features strongly suggest CMT2 and a DYNC1H1 mutation is suspected, focused sequencing of this gene may be ordered. Finding a heterozygous pathogenic variant in DYNC1H1 establishes the diagnosis of CMT2O according to current genetic criteria. MDPI+1Sural nerve biopsy (now rarely needed)
In unclear cases, especially before advanced genetic tests were widely available, doctors sometimes took a small sample of a sensory nerve (usually the sural nerve in the lower leg). In axonal CMT like CMT2O, the biopsy typically shows loss of myelinated axons with few demyelinating changes, supporting an axonal hereditary neuropathy. MD Searchlight
Electrodiagnostic tests
Nerve conduction studies (NCS/NCV)
Nerve conduction studies measure how fast and how strong electrical signals travel along motor and sensory nerves. In CMT2O, motor and sensory conduction velocities are often normal or only slightly slowed, but the response sizes (amplitudes) are reduced, which fits an axonal neuropathy pattern. Mayo Clinic+2MD Searchlight+2Electromyography (EMG)
EMG uses a fine needle electrode to record electrical activity inside muscles at rest and during contraction. In CMT2O, EMG typically shows chronic denervation and reinnervation changes in distal muscles, confirming that the weakness is due to long-standing nerve damage rather than a primary muscle disease. Mayo Clinic+1F-wave and late response studies
F-waves are special nerve conduction responses that travel from the muscle back to the spinal cord and then down again. In some CMT2 patients, including those with CMT2O, these late responses may be reduced or absent in severely affected nerves, adding supporting evidence of a diffuse axonal neuropathy. eMedicine+1Somatosensory evoked potentials (when central involvement is suspected)
In patients with unusual signs such as spasticity or clear central nervous system features, doctors may use somatosensory evoked potentials to test pathways from the limb to the brain. Abnormalities can show central involvement as part of the broader DYNC1H1-related disorder spectrum linked to the same gene that causes CMT2O. NCBI+2Wikipedia+2
Imaging tests
MRI of the spine and brain
MRI is not required to diagnose CMT2O, but it is sometimes ordered to rule out other causes of weakness and sensory problems, such as spinal cord lesions. In patients with DYNC1H1-related brain involvement, MRI may show cortical malformations or other changes that fit the broader dyneinopathy picture. NCBI+2Wikipedia+2Musculoskeletal X-rays of feet and spine
X-rays of the feet can show high arches, hammertoes, and other deformities that guide orthopedic and physiotherapy planning. Spinal X-rays can detect or monitor scoliosis in patients with long-standing muscle imbalance due to CMT2O. Mayo Clinic+2NCBI+2Ultrasound of peripheral nerves and muscles
High-resolution ultrasound can visualize peripheral nerves and sometimes show reduced size or altered structure in hereditary neuropathies. It can also assess muscle bulk and help distinguish neurogenic from other causes of limb weakness, although it is a complementary tool rather than a primary diagnostic test. Cleveland Clinic+1Genetic counseling assessment
While not a laboratory or imaging “test” in the narrow sense, meeting with a genetic counselor is a key diagnostic and management step. Counselors interpret genetic test results for DYNC1H1 and related genes, explain inheritance patterns, and help family members decide whether to be tested or how to plan for the future. NCBI+1
Non-pharmacological treatments for CMT2O
These treatments do not use drugs. They support the nerves, muscles, joints, and your daily life.
Individualized physical therapy program
A physical therapist creates a special exercise plan for your body, strength, and balance. It often includes stretching, strengthening, and balance work. The goal is to slow muscle weakness, keep joints moving, and reduce contractures (stiff, shortened muscles). Research shows that regular physiotherapy helps people with CMT stay mobile and reduces long-term complications. Physiopedia+2nhs.uk+2Strength and resistance training
Light to moderate resistance exercises (for example, bands or light weights) focus on muscles that are weak but still “working” enough to train. The purpose is to keep muscles as strong as possible without over-fatiguing them. Studies suggest carefully supervised strength training can improve function in CMT, but over-training should be avoided to protect fragile nerves and muscles. PubMed+1Stretching and range-of-motion exercises
Daily stretching of ankles, knees, hips, fingers, and wrists helps keep joints flexible. This can lower the risk of contractures and painful stiffness. The mechanism is simple: slow, gentle stretches lengthen tight muscles and tendons, helping them glide better over joints and improving walking and hand use. Physiopedia+1Balance and proprioception training
CMT2O damages sensory nerves, so the brain gets weaker signals from the feet and legs. Balance exercises (standing on foam, tandem walking, gentle balance boards under supervision) train the body to use vision, inner ear, and remaining nerve signals more effectively. This reduces falls and builds confidence in walking. MDPI+1Gait training
A therapist can analyze your walking pattern and teach safer ways to walk, turn, and climb stairs. They may suggest specific exercises or devices to correct foot drop or high arches. Training aims to reduce tripping, improve speed and endurance, and make your walking pattern more energy-efficient. MDPI+1Occupational therapy for hand and daily tasks
Occupational therapists focus on hand weakness, fine motor skills, and daily activities like writing, typing, dressing, and using utensils. They may suggest hand exercises and adaptive tools such as built-up pens or button hooks. The goal is independence at school, home, and work, even when grip and coordination are reduced. Charcot-Marie-Tooth Association+1Ankle-foot orthoses (AFOs)
AFOs are braces that support the ankle and foot. They help lift the toes during walking and keep the ankle stable. This reduces foot drop and ankle rolling, helps you walk more smoothly, and lowers the chance of falls. Studies in CMT show that braces can improve gait and decrease fatigue when walking. SCIRP+1In-shoe orthotics and specialized footwear
Soft insoles, arch supports, and custom shoes help support high arches or other foot shapes. They work by spreading pressure more evenly and improving alignment. This can reduce pain under the foot, prevent calluses and ulcers, and make walking more comfortable for longer distances. Wikipedia+2SCIRP+2Walking aids (cane, crutches, walker)
If balance or leg strength becomes very weak, a cane or walker can improve stability. These devices shift some body weight to the arms and provide extra points of contact with the ground. They can reduce fear of falling and allow safer, longer walking. Muscular Dystrophy Association+1Regular aerobic exercise
Low-impact activities such as swimming, stationary cycling, or gentle walking keep the heart and lungs healthy. For adults with CMT, around 150 minutes of moderate aerobic activity per week is often suggested, adjusted to personal ability. Exercise helps maintain general strength, mood, and weight, which all protect joints and nerves. Charcot-Marie-Tooth Disease+2PubMed+2Energy conservation and fatigue management
Many people with CMT feel tired easily. Therapists teach pacing strategies: planning rests, sitting for tasks when possible, and spreading heavy activities across the day. This protects muscles from overuse and helps you save energy for important activities like school or work. Charcot-Marie-Tooth Association+1Home safety changes
Simple changes like removing loose rugs, adding grab bars, improving lighting, and using non-slip mats reduce fall risk. These environmental changes work by reducing tripping hazards and giving extra support in risky areas like bathrooms or stairs. Charcot-Marie-Tooth Association+1Fall-prevention programs
Some clinics offer structured fall-prevention classes that combine strength, balance, and education. Learning how to fall more safely, how to get up from the floor, and when to use aids can prevent serious injuries such as fractures and head injury. MDPI+1Foot care and podiatry
Regular nail care, callus removal, inspection for cuts, and proper footwear are important, especially because sensation in the feet is often reduced. A podiatrist can treat pressure areas early and recommend shoes that protect the skin, lowering the risk of ulcers and infections. ScienceDirect+1Psychological support and counseling
Living with a chronic, inherited condition can cause anxiety, low mood, or body-image concerns. Talking with a psychologist or counselor helps people cope, manage stress, and build resilience. Supportive therapy can improve quality of life even though it does not change the nerves themselves. PMC+1Vocational counseling and school accommodations
Specialists can help plan school or career paths that fit your physical abilities, suggest ergonomic work setups, and help arrange extra time for exams or assistive technology. This prevents unnecessary strain and helps you stay engaged in study and work. PMC+1Assistive devices for hands and daily activities
Tools like easy-grip cutlery, zipper pulls, or speech-to-text software reduce the effort needed for tasks. They work by bypassing weak muscles and giving mechanical help, so you can still do activities independently and safely. Charcot-Marie-Tooth Association+1Genetic counseling for patient and family
Genetic counselors explain how CMT2O is inherited and what the chances are of passing it to children. They discuss genetic testing options and future family planning choices. This gives emotional support and helps families make informed decisions. MalaCards+1Peer support groups and patient organizations
Groups such as national CMT associations offer education, emotional support, and shared experiences. Meeting others with CMT reduces isolation, provides practical tips, and keeps you updated about research studies and clinical trials. Charcot-Marie-Tooth Association+1Regular follow-up in a CMT or neuromuscular clinic
Ongoing visits allow your team to track progression, adjust braces and therapies, treat pain early, and watch for complications such as scoliosis or severe foot deformity. Long-term, structured follow-up is key for good outcomes in inherited neuropathies. PMC+1
Drug treatments for symptoms in CMT2O
Right now, no medicine is officially approved to cure or directly stop CMT2O. Drug treatment focuses on symptoms, especially neuropathic pain, muscle cramps, mood problems, and sleep. Most of these medicines are approved by the U.S. FDA for other types of nerve pain (like diabetic neuropathy or post-herpetic neuralgia), not specifically for CMT, and are used “off-label” under specialist guidance. FDA Access Data+4ScienceDirect+4Muscular Dystrophy Association+4
Doses below are typical adult ranges from FDA labels; for children/teens, dosing is different and must be set by a pediatric neurologist. FDA Access Data+2FDA Access Data+2
Gabapentin (antiepileptic, neuropathic pain)
Gabapentin is used to treat nerve pain and seizures. A common adult dose for neuropathic pain starts around 300 mg at night and may increase up to 1800–3600 mg/day in divided doses, adjusted by a doctor. It calms over-active nerve cells by affecting calcium channels. Side effects can include sleepiness, dizziness, and weight gain. FDA Access Data+1Pregabalin (antiepileptic, neuropathic pain)
Pregabalin is FDA-approved for several neuropathic pain conditions. Typical adult doses range from 150–600 mg/day, divided into two or three doses. It helps by reducing the release of pain-signaling chemicals in nerves. Common side effects are dizziness, drowsiness, swelling of legs, and weight gain. FDA Access Data+1Duloxetine (SNRI antidepressant, neuropathic pain)
Duloxetine is approved for diabetic nerve pain and fibromyalgia. Adult doses often start at 30 mg once daily, increasing to 60 mg/day as tolerated. It boosts serotonin and norepinephrine levels, which can reduce pain signals and improve mood. Side effects may include nausea, dry mouth, sleep changes, and increased sweating. FDA Access Data+1Amitriptyline (tricyclic antidepressant)
Amitriptyline is an older antidepressant often used at low doses (10–75 mg at night) for chronic nerve pain. It may reduce pain by blocking reuptake of serotonin and norepinephrine and modulating pain pathways in the spinal cord. Side effects can include dry mouth, constipation, drowsiness, and, rarely, heart rhythm problems, so careful monitoring is needed. Medical Guidelines+1Nortriptyline (tricyclic antidepressant)
Nortriptyline is similar to amitriptyline but sometimes better tolerated. Typical nerve-pain doses are 25–75 mg at night, individualized by the doctor. It works on the same chemical messengers as amitriptyline. Side effects can include dry mouth, constipation, blurred vision, and dizziness, especially when doses are increased quickly. Medical Guidelines+1Venlafaxine (SNRI antidepressant)
Venlafaxine is mainly used for depression and anxiety, but can sometimes help neuropathic pain. Doses often range from 75–225 mg/day. It increases serotonin and norepinephrine in the brain and spinal cord, which may dampen pain signals. Side effects include nausea, sweating, increased blood pressure, and insomnia in some people. PMCCarbamazepine (antiepileptic, neuropathic pain)
Carbamazepine is used for trigeminal neuralgia and seizures, and sometimes for severe nerve pain. Adult doses vary widely but often start low (100–200 mg/day) and are slowly increased. It stabilizes over-excited nerve membranes by blocking sodium channels. Side effects can include dizziness, low blood counts, liver issues, and allergic skin reactions, so blood tests are needed. FDA Access Data+1Oxcarbazepine (antiepileptic)
Oxcarbazepine is similar to carbamazepine but may have a slightly different side-effect pattern. Doses typically range from 600–2400 mg/day in divided doses. It blocks sodium channels to calm over-firing nerves. Common side effects are dizziness, fatigue, low sodium levels, and allergic rash, so blood tests are sometimes checked. nhs.ukTopical lidocaine 5% patch or gel
Lidocaine patches are FDA-approved for post-herpetic neuralgia and sometimes used for localized neuropathic pain. They are usually applied once daily for up to 12 hours to intact skin over painful areas. Lidocaine numbs the local nerves by blocking sodium channels. Side effects are usually mild skin irritation or redness where the patch is applied. Ovid+1Topical capsaicin (cream or high-dose patch)
Capsaicin comes from chili peppers. Low-strength cream is used several times per day; high-dose patches are applied less often in specialist settings. It depletes “substance P,” a chemical linked to pain, from nerve endings. At first it can cause burning or stinging, but this usually settles with time. NCBI+1Simple pain relievers (paracetamol/acetaminophen)
Acetaminophen can help mild pain and is often used as a first step. Adult doses must stay within safe daily limits (commonly not more than 3,000–4,000 mg/day, depending on the label and liver health). It reduces pain and fever through central mechanisms in the brain. Side effects are usually mild but overdose can cause serious liver damage. NCBINon-steroidal anti-inflammatory drugs (NSAIDs)
Ibuprofen and naproxen may help with joint and muscle pain rather than nerve pain itself. They block cyclo-oxygenase (COX) enzymes, lowering inflammation chemicals called prostaglandins. Typical adult doses are 400–800 mg ibuprofen three times daily or 250–500 mg naproxen twice daily, but long-term use can irritate the stomach and affect kidneys or heart risk. NPS+1Tramadol (weak opioid with SNRI effect)
Tramadol is sometimes used for short-term moderate pain when other options fail. Adult doses usually range 50–400 mg/day, divided. It acts on opioid receptors and also boosts serotonin and norepinephrine. Side effects can include nausea, dizziness, sleepiness, and, at high doses, seizure risk or dependence, so it must be used carefully and briefly. GMMMGBaclofen (muscle relaxant)
Baclofen is used to treat muscle stiffness and spasms. Doses commonly start at 5 mg three times daily and are slowly increased. It works on GABA-B receptors in the spinal cord to reduce muscle over-activity. Side effects include drowsiness, weak muscles, and, if stopped suddenly after high doses, withdrawal symptoms; tapering is needed. WikipediaTizanidine (muscle relaxant)
Tizanidine helps with spasticity and painful muscle tightness. Typical adult dosing starts low (2–4 mg) and builds up to multiple doses per day. It acts on alpha-2 receptors to reduce nerve signals that cause muscle contraction. Side effects include low blood pressure, dry mouth, and drowsiness; liver function is sometimes monitored. palliativedrugs.orgLow-dose benzodiazepines (e.g., clonazepam) for severe nighttime cramps – specialist use only
In selected adults with severe cramps or anxiety, very low doses may be used for short periods. They boost GABA activity in the brain, calming muscles and nerves. Side effects include drowsiness, dizziness, and dependence risk, so they are usually a last resort and avoided in many patients, especially teens. Drugs.comSelective serotonin reuptake inhibitors (SSRIs) for mood
SSRIs like sertraline or citalopram do not directly treat nerve damage, but they help depression and anxiety, which are common in chronic illness. Better mood can improve pain coping and activity levels. Side effects may include stomach upset, sleep changes, and, rarely, increased anxiety early in treatment. PMC+1Sleep medicines or melatonin (short term, under guidance)
When pain or cramps disturb sleep, short-term sleep aids or melatonin may be considered. They aim to restore a regular sleep pattern, which improves pain tolerance and daytime energy. Side effects depend on the drug; melatonin is usually mild but can cause vivid dreams or drowsiness. Charcot-Marie-Tooth Association+1Treatment of co-existing conditions (e.g., thyroid, vitamin deficiencies)
If you also have thyroid disease, diabetes, or vitamin deficiencies, the correct medicines for those problems are essential. Treating these conditions can reduce extra stress on nerves and muscles. For example, vitamin B12 injections can improve nerve problems due to B12 deficiency. AAFP+2ScienceDirect+2Clinical-trial medicines specific for CMT (future-focused)
Several experimental drugs, such as NMD670 or RTX-117, are in clinical trials for different types of CMT. These aim to improve nerve or muscle function at a deeper, molecular level but are not yet approved for general use. Participation is only through supervised clinical studies. firstwordpharma.com+4NMD Pharma+4Charcot-Marie-Tooth Association+4
Dietary molecular supplements
Supplements do not replace a balanced diet or medical treatment. Evidence often comes from studies in diabetic neuropathy or general nerve health, not specifically CMT2O.
Alpha-lipoic acid (ALA)
ALA is an antioxidant that may reduce oxidative stress in nerves. Studies in diabetic neuropathy suggest doses around 600 mg/day can improve pain and symptoms in some patients, though results are mixed. It works by neutralizing free radicals and improving blood flow to nerves. Side effects can include stomach upset and rare low blood sugar. Cureus+3neurology.org+3PubMed+3Acetyl-L-carnitine (ALC)
ALC helps mitochondria (cell “power plants”) produce energy. Several trials in peripheral neuropathy report moderate pain relief and possible nerve regeneration at doses around 1,000–3,000 mg/day, divided. It may support nerve repair by improving energy supply and promoting nerve fiber regrowth. Side effects are usually mild, such as nausea or restlessness. Diabetes Journals+4PLOS+4aidsmap.com+4Omega-3 fatty acids (fish oil, DHA/EPA)
Omega-3 fats from fish oil may protect nerves and help regeneration in animal models. Typical supplement doses are 1–3 g/day combined EPA/DHA, under medical guidance. They may reduce inflammation and support nerve membrane repair, although human neuropathy data are limited and mixed. Side effects can include fishy aftertaste and, at high doses, bleeding risk. ScienceDirect+4Frontiers+4Omegor.com+4Vitamin B12 (cobalamin)
B12 is vital for making myelin (the nerve “insulation”) and healthy red blood cells. Doses vary: mild deficiency may use oral 1,000 µg/day; severe deficiency often needs injections, according to guidelines. Correcting low B12 can improve numbness and tingling due to deficiency and prevents permanent damage. Side effects are rare but can include acne-like rash or, very rarely, allergic reactions. Health+4Cleveland Clinic+4AAFP+4Vitamin B1 (thiamine or benfotiamine)
Thiamine is important for nerve metabolism. Benfotiamine, a fat-soluble form, has been studied in diabetic neuropathy at doses around 150–600 mg/day and may improve symptoms by reducing harmful sugar-related damage in nerves. Side effects are usually mild digestive discomfort. The Foundation for Peripheral Neuropathy+1Vitamin B6 (pyridoxine – careful with dose)
B6 supports nerve function but is a double-edged sword: too much for long periods can itself cause neuropathy. Low to moderate doses (e.g., 2–25 mg/day as part of a B-complex) are generally safe; high doses (100–200 mg/day or more) should be avoided unless prescribed. The Foundation for Peripheral Neuropathy+1Vitamin D
Vitamin D is important for bone and muscle health. Many people with chronic illness have low levels. Typical replacement doses range widely (e.g., 800–2,000 IU/day or more under medical guidance). Correcting deficiency can support muscle function and reduce fall risk, even though it does not directly repair nerves. European CMT Federation+1Magnesium
Magnesium helps muscles relax and supports nerve signaling. Some people find it eases cramps or twitching. Common supplement doses are 200–400 mg/day, depending on the form and kidney function. Too much can cause diarrhea, and very high doses are unsafe in kidney disease. European CMT Federation+1Coenzyme Q10 (CoQ10)
CoQ10 supports mitochondrial energy production and acts as an antioxidant. Supplements (often 100–300 mg/day) are used in some neuromuscular conditions, though direct evidence in CMT is limited. It may help energy levels and muscle performance in some patients. Side effects are usually mild stomach upset. European CMT Federation+1Curcumin (from turmeric)
Curcumin has anti-inflammatory and antioxidant effects. Doses vary (often 500–1,000 mg/day of standardized extract), usually taken with food and sometimes with black pepper to improve absorption. It may reduce inflammation in nerves and joints, but neuropathy data are limited. Side effects can include stomach upset or reflux in some people. Diabetes Journals+1
Regenerative, immune and stem-cell–related drugs
These treatments are not standard care for CMT2O. Most are in early research or clinical trials and are only available through specialist centers.
EN001 (mesenchymal stem cell therapy, investigational)
EN001 uses stem cells from umbilical cord tissue (Wharton’s jelly). Early trials in CMT1A show improved neuropathy scores and muscle strength, and the FDA has given it orphan-drug designation for CMT. It likely works by releasing growth factors that support nerve myelin and reduce inflammation. It is given intravenously under strict trial conditions. firstwordpharma.com+4ClinicalTrials+4Charcot-Marie-Tooth Association+4NMD670 (ClC-1 channel inhibitor, investigational)
NMD670 is an oral small molecule designed to improve communication between nerves and muscles by inhibiting a specific muscle chloride channel (ClC-1). It has FDA orphan-drug status for CMT, and a Phase 2 trial (SYNAPSE-CMT) is underway in adults with CMT1 and CMT2. The aim is to improve muscle strength and fatigue. NMD Pharma+4NMD Pharma+4Charcot-Marie-Tooth Association+4RTX-117 (eIF2B activator, investigational)
RTX-117 is a small-molecule therapy that targets eIF2B, a protein complex involved in making many other proteins in cells. It is designed to restore normal protein production and address one underlying cause of CMT rather than just treating symptoms. The FDA has granted orphan-drug designation for CMT, but it is still in early development. LinkedIn+4revirtx.com+4bioworld.com+4AAV9-based gene therapy for CMT subtypes (preclinical/early clinical)
Researchers are testing gene therapy using an adeno-associated virus (AAV9) to deliver healthy copies or modifiers of CMT-related genes. In mouse models of CMT4J, AAV9-mediated FIG4 gene delivery prolonged life and improved nerve function. Similar strategies are being explored for multiple CMT types and may one day be adapted for DYNC1H1-related CMT2O. Wiley Online Library+4PMC+4PubMed+4General gene-therapy platforms for CMT (research)
Gene-therapy programs for CMT use techniques like gene replacement, gene silencing, or editing (for example, CRISPR-based methods) to correct faulty genes in Schwann cells or neurons. These approaches are still experimental but show promise in animal models and early human trials for other neuropathies. CMT Research Foundation+2Wiley Online Library+2Future immune-modulating and neurotrophic factor therapies
Some research looks at drugs that boost protective growth factors or modulate cell-stress responses to protect axons in inherited neuropathies. These might include engineered growth factors or small molecules that improve cellular stress handling. None are standard for CMT2O yet, but they represent important “regenerative” directions for the future. AFM Téléthon+2ScienceDirect+2
Surgical options in CMT2O
Surgery in CMT2O does not fix the nerve damage. It is used to correct foot deformities, improve alignment, and reduce pain when braces and therapy are not enough. nhs.uk+3PMC+3Charcot-Marie-Tooth Association+3
Tendon transfer procedures
In tendon transfers, a stronger tendon is detached and moved to help a weaker muscle group (for example, moving a tendon to help lift the front of the foot). This can improve foot drop and balance. The main goal is a more stable, plantigrade (flat) foot and better walking.Osteotomy (bone-cutting surgery)
Osteotomies reshape or realign bones in the foot, such as the first metatarsal or heel bone, to correct high arches and heel varus. By changing bone angles, surgeons can redistribute weight, reduce pain, and make it easier to fit into normal shoes. ResearchGate+3PubMed+3www.elsevier.com+3Plantar fascia release and soft-tissue lengthening
Tight bands and tendons under the foot and in the calf can be surgically lengthened or released. This increases ankle and toe flexibility, reduces clawing of the toes, and helps the foot sit flat on the ground.Joint fusion (arthrodesis, e.g., triple arthrodesis or ankle fusion)
In very stiff or arthritic feet, surgeons may fuse certain joints so they no longer move. This can greatly improve stability and pain, at the cost of some flexibility. It is usually reserved for severe deformities after other options have failed. nmd-journal.com+2PMC+2Toe straightening and lesser procedures
For painful claw toes, small joint fusions or tendon releases may straighten the toes. This reduces shoe pressure, calluses, and pain when walking. These procedures are often combined with larger reconstructive surgeries for the whole foot. enmc.org+1
Prevention and protection:
You cannot prevent being born with CMT2O, but you can reduce complications:
Keep a regular physiotherapy and stretching routine to avoid contractures. Physiopedia+1
Use braces or orthotics as prescribed to support the feet and ankles. SCIRP+1
Maintain a healthy weight to reduce load on weak muscles and joints. European CMT Federation+1
Avoid smoking and heavy alcohol, which can worsen nerve damage. European CMT Federation+1
Choose low-impact exercise rather than high-impact sports that cause repeated ankle injuries. Charcot-Marie-Tooth Disease+1
Protect your feet with good shoes and daily inspection for cuts or blisters. Charcot-Marie-Tooth Association+1
Treat infections and injuries early to avoid long-term problems. PMC+1
Keep other conditions (like diabetes or vitamin deficiencies) well controlled. The Foundation for Peripheral Neuropathy+1
Use home safety changes (grab bars, no loose rugs) to prevent falls. Charcot-Marie-Tooth Association+1
Stay in touch with a specialist clinic to monitor progression and new treatment options, including trials. PMC+1
When to see a doctor
You should see a doctor (ideally a neurologist with experience in CMT or a pediatric neurologist for teens) if:
You notice new weakness, especially if it suddenly worsens.
Walking becomes harder, or you start tripping and falling more often.
You develop severe pain, burning, or numbness that does not improve with simple measures.
Your foot shape changes quickly (more high arch, twisted foot, claw toes).
You get sores, ulcers, or infections on your feet that do not heal.
You have breathing, swallowing, or severe back pain (rare but important). PMC+2Charcot-Marie-Tooth Association+2
Emergency help is needed if you have sudden severe weakness, breathing trouble, chest pain, very high fever, or signs of serious infection.
What to eat and what to avoid
Food will not cure CMT2O, but it supports overall nerve and muscle health.
Eat plenty of fruits and vegetables
Aim for colorful fruits and vegetables every day to provide vitamins, minerals, and antioxidants that support nerve and muscle health. European CMT Federation+1Choose lean protein
Include fish, poultry, eggs, beans, and lentils. Protein helps repair muscle tissue and maintain strength. Charcot-Marie-Tooth News+1Focus on whole grains
Whole-grain bread, brown rice, and oats give slow, steady energy and fiber, helping with blood-sugar control and weight management. European CMT FederationInclude healthy fats
Nuts, seeds, olive oil, and oily fish provide healthy fats. Omega-3 fats from fish may help nerve health and reduce inflammation. Frontiers+2Understanding Animal Research+2Limit sugary drinks and sweets
Too much sugar can lead to weight gain and higher risk of diabetes, which can further damage nerves. Choose water most of the time. European CMT Federation+1Avoid large amounts of alcohol
Heavy alcohol use can cause its own neuropathy and worsen balance and falls. If allowed at all, it should be very limited and always discussed with a doctor. The Foundation for Peripheral Neuropathy+1Do not smoke or vape nicotine
Smoking reduces blood flow to nerves and muscles and may speed up weakness. Avoiding nicotine helps overall circulation and healing. European CMT Federation+1Stay hydrated
Drinking enough water helps muscle and joint function and can reduce fatigue. Dehydration can worsen cramps and dizziness.Be careful with “mega-dose” supplements
Very high doses of vitamins, especially B6, can actually harm nerves. Always ask your doctor before taking strong supplements. The Foundation for Peripheral Neuropathy+1Work with a dietitian if weight is an issue
If you are underweight or overweight, a dietitian can design meals that match your energy needs and physical abilities, helping you maintain mobility and health. European CMT Federation+1
Frequently asked questions
1. Can Charcot-Marie-Tooth neuropathy type 2O be cured?
No. At present there is no cure that removes the genetic change or fully repairs the damaged axons. Treatment aims to preserve function, manage symptoms, and prevent complications. Research in gene therapy and stem-cell approaches is ongoing. AFM Téléthon+3MalaCards+3ScienceDirect+3
2. Will I always end up in a wheelchair?
Not necessarily. CMT2O is usually slowly progressive, and many people remain able to walk, especially with good physiotherapy, braces, and surgery if needed. Some may need walking aids later in life. Early, consistent management often leads to better long-term mobility. MalaCards+2Physiopedia+2
3. Is CMT2O life-threatening?
Most people with CMT2O have a normal life span. The main problems involve mobility, pain, and foot deformities. Rare complications such as severe scoliosis or breathing issues can be serious, but these are less common and are monitored in specialist clinics. MalaCards+1
4. How is CMT2O different from other CMT types?
CMT2O is an axonal type caused mainly by mutations in DYNC1H1. Nerve conduction velocities are usually near normal or mildly reduced, but the signal strength (amplitude) is low because axons are lost. Some people also have other features like spasticity or developmental issues. MalaCards+2NCBI+2
5. Can exercise make my nerves worse?
Normal, moderate exercise usually does not harm nerves and may benefit strength and balance. Over-strenuous, high-impact exercise that causes repeated injuries or severe exhaustion can be harmful. A therapist can design a safe program adapted to your abilities. PubMed+2Charcot-Marie-Tooth Disease+2
6. Which doctor should manage CMT2O?
A neurologist with experience in neuromuscular or CMT disorders is ideal. They often work with physiatrists, physical and occupational therapists, orthotists, surgeons, psychologists, and genetic counselors in a multidisciplinary team. PMC+1
7. Is pain always part of CMT2O?
Not always. Some people have minimal pain, while others experience burning, tingling, or aching. Neuropathic pain drugs, braces, and exercise can help. Pain management should be individualized, and non-drug strategies are also important. ScienceDirect+2Charcot-Marie-Tooth Association+2
8. Can supplements replace my medicines?
No. Supplements can sometimes support nerve and muscle health, but they do not replace prescribed medicines or therapies. Some supplements interact with drugs or are unsafe at high doses, so always review them with your doctor. ScienceDirect+3Diabetes Journals+3epistemonikos.org+3
9. Should my family be tested for CMT2O?
Because CMT2O is usually autosomal dominant, close relatives may want genetic counseling and possibly testing. The decision depends on age, symptoms, and personal preferences and should be guided by a genetics professional. MalaCards+1
10. Are there special shoes for CMT?
Yes. Many people benefit from supportive shoes with a wide toe box, firm heel counter, and space for braces or orthotics. A podiatrist or orthotist can help choose or custom-make shoes that protect your feet and improve walking. Wikipedia+2SCIRP+2
11. How often should I see a neurologist?
This depends on how fast your symptoms are changing. Many people are seen once or twice a year for review; more frequent visits may be needed during rapid changes, new pain, or when planning surgery or new devices. PMC+1
12. Can I join a clinical trial?
Possibly. Trials for drugs like NMD670, EN001, and other experimental therapies usually include adults with certain CMT types and confirmed genetic results. Trial availability depends on your country and center. CMT organizations and your neurologist can help you look for trials. NMD Pharma+4Charcot-Marie-Tooth Association+4Charcot-Marie-Tooth Association+4
13. Will surgery stop my CMT from progressing?
No. Surgery corrects foot and ankle deformities and can improve pain and walking, but it does not fix the underlying nerve problem. Nerves may still slowly worsen over time, so ongoing therapy and follow-up remain important. PMC+2Charcot-Marie-Tooth Association+2
14. Is CMT2O common?
No, it is very rare. CMT as a whole is one of the most common inherited nerve diseases, but CMT2O is only a tiny fraction of all CMT cases and may affect fewer than one in a million people. MalaCards+2Pak J Neurol Sci+2
15. What is the most important thing I can do right now?
The most important steps are: get a clear diagnosis with genetic testing, build a relationship with a neuromuscular specialist team, start appropriate physical and occupational therapy, protect your feet and balance, and look after your general health (sleep, diet, mood). These basics give the best chance for staying active and independent for as long as possible. ScienceDirect+3PMC+3Physiopedia+3
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: December 22, 2025.
